Work

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Year: 2019

Type: article

Study design: Observational Study

Source: Mayo Clinic Proceedings

DOI: 10.1016/j.mayocp.2018.08.039

Authors: Surbhi Sidana, Nidhi Tandon, Peter A. Brady, Martha Grogan, Morie A. Gertz, Angela Dispenzieri, Grace Lin, David Dingli, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, Wilson I. Gonsalves, Eli Muchtar, Rahma Warsame, Shaji K. Kumar, Taxiarchis V. Kourelis

Institution: Mayo Clinic

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Bristol-Myers Squibb, Pfizer, Merck, Novartis, Sanofi, Alnylam Pharmaceuticals, Celgene, AbbVie, Takeda Pharmaceutical Company, Ionis Pharmaceuticals, Prothena, MedImmune, Johnson and Johnson, Kite Pharma, Janssen Pharmaceuticals

OpenAlex ID: W2911811323

FWCI: 1.147

Cites: 36

Cited by: 23

Related to: 10